N-(2,4-Difluorophenyl)-1-methyl-3-(trifluoromethyl)-5-[3-(trifluoromethyl)phenoxy]-1H-pyrazole-4-carboxamide CAS 282523-35-7
Purity 97%+In StockPharmaceutical Standards
| CAS No. | 282523-35-7 |
| Molecular Formula | C19H11F8N3O2 |
| Molecular Weight | 465.30 g/mol |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
Chemical Structure
Description
N-(2,4-Difluorophenyl)-1-methyl-3-(trifluoromethyl)-5-[3-(trifluoromethyl)phenoxy]-1H-pyrazole-4-carboxamide (CAS 282523-35-7) reference standard, produced by CATO (ISO 17034 / CNAS / ANAB accredited). Molecular formula: C19H11F8N3O2. Molecular weight: 465.30 g/mol. Trusted by 10,000+ laboratories worldwide for pharmaceutical analysis and QC.
Physical & Chemical Properties
| Molecular Formula | C19H11F8N3O2 |
| Molecular Weight | 465.30 g/mol |
| Appearance | Pale yellow to yellow crystalline powder. (slight halide-like odor, low volatility) |
| Purity | 97%+ |
| Storage | Store in a cool place (≤25°C), protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 12.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 2025 |
| Halogen Content | F-containing |
| Nitrogen Atoms | 3 |
Related N Standards
- 2-(3,4-Difluorophenyl)-4-(3-hydroxy-3-methylbutoxy)-5-(4-(methylsulfonyl)phenyl)pyridazin-3(2H)-one (CAS 266320-83-6)
- 1-(2,4-Difluorophenyl)-6-oxo-4-(trifluoromethyl)-N-(4-(trifluoromethyl)phenyl)-1,6-dihydropyridazine-3-carboxamide (CAS 477859-68-0)
- N-(2,4-Difluorophenyl)-2-((4-(4-ethoxyphenyl)-5-(pyridin-3-yl)-4H-1,2,4-triazol-3-yl)thio)acetamide (CAS 618432-47-6)
- N-(3,4-Difluorophenyl)-2-((4-(4-ethoxyphenyl)-5-(pyridin-3-yl)-4H-1,2,4-triazol-3-yl)thio)acetamide (CAS 477330-08-8)
- 1-(2,4-Difluorophenyl)-7-(3,5-dimethylpiperazin-1-yl)-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (CAS 182869-17-6)
- 1-(2,4-Difluorophenyl)-7-(4-ethylpiperazin-1-yl)-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (CAS 182869-19-8)
- 1-(3,4-Difluorophenyl)-3-(4-((6,7-dimethoxyquinolin-3-yl)oxy)-2-fluorophenyl)urea (CAS 1956311-09-3)
- 1-(3,4-Difluorophenyl)-3-(4-((6,7-dimethoxyquinolin-4-yl)oxy)-2-fluorophenyl)urea (CAS 228559-81-7)
Recommended Standards
- 1-[(4-Bromo-2-methyl-5-oxo-1-phenyl-2,5-dihydro-1H-pyrazol-3-yl)methyl]-4-(4-methoxyphenyl)-1H-1,2,3-triazole-5-carbonitrile (CAS 1024251-40-8)
- Bromo-PEG5-phosphonic acid diethyl ester (CAS 1446282-41-2)
- 5-(3-(Benzyloxy)-6-bromo-1-fluoronaphthalen-2-yl)-1,2,5-thiadiazolidin-3-one 1,1-dioxide (CAS 2489410-97-9)
- Ethyl 4-chloro-1,5-naphthyridine-3-carboxylate (CAS 83067-95-2)
- (4-Chloro-3-fluorophenyl)(4-chlorophenyl)methanone (CAS 951890-56-5)
- Phenyl 4-phenyl-5-(trifluoromethyl)thiophene-2-carboxylate (CAS 256348-27-3)
- 5-Bromo-2-(bromomethyl)pyrimidine (CAS 1193116-74-3)
- (3-Hydroxy-pyrrolidin-1-yl)-acetic acid hydrochloride (CAS 1187931-13-0)
- 2-(4-Chlorophenyl)-N-((dimethylamino)methylene)-2-(3-(trifluoromethyl)quinoxalin-2-yl)acetamide (CAS 338412-27-4)
- Urotensin II-Related Peptide (human, mouse, rat) (CAS 342878-90-4)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 13829788188 / jacky.chen@cato-chem.com